Praxis Precision Medicines (PRAX) Capital Expenditures (2020 - 2025)
Praxis Precision Medicines' (PRAX) quarterly Capital Expenditures came in at -$8000.0 in Q3 2025, down 112.5% quarter-over-quarter from $64000.0 in Q1 2025.
Praxis Precision Medicines (PRAX) Capital Expenditures (2020 - 2025) Analysis & Trends
Praxis Precision Medicines' Capital Expenditures history runs 5 years deep, the most recent figure standing at -$8000.0 for Q3 2025.
- On a quarterly basis, Capital Expenditures changed N/A year-over-year to -$8000.0 in Q3 2025; TTM through Mar 2026 was -$8000.0, a 112.5% decrease from a year earlier, with the FY2025 full-year figure at $56000.0, changed N/A from the prior year.
- Capital Expenditures retreated to -$8000.0 in Q3 2025 per PRAX's latest filing, from $64000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $444000.0 in Q4 2022 and bottomed at -$399000.0 in Q3 2022.
- The 4-year median for Capital Expenditures is $64000.0 (2025), against an average of $74272.7.
- Biggest YoY gain for Capital Expenditures was 7125.0% in 2022; the steepest drop was 1309.09% in 2022.
- Year by year, Capital Expenditures stood at $151000.0 in 2021, then soared by 194.04% to $444000.0 in 2022, then plunged by 88.74% to $50000.0 in 2023, then sank by 116.0% to -$8000.0 in 2025.
- Per Business Quant, the three latest PRAX Capital Expenditures figures stand at -$8000.0 (Q3 2025), $64000.0 (Q1 2025), and $50000.0 (Q3 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Praxis Precision Medicines | 8.98 Bn | 8.20 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -8,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Mar 31, 2025 | 64,000.00 |
| Mar 31, 2025 | 64,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Dec 31, 2022 | 444,000.00 |
| Dec 31, 2022 | 444,000.00 |
| Sep 30, 2022 | -399,000.00 |
| Sep 30, 2022 | -399,000.00 |
| Jun 30, 2022 | 110,000.00 |
| Jun 30, 2022 | 110,000.00 |
| Mar 31, 2022 | 289,000.00 |
| Mar 31, 2022 | 289,000.00 |
| Dec 31, 2021 | 151,000.00 |
| Dec 31, 2021 | 151,000.00 |
| Sep 30, 2021 | 33,000.00 |
| Sep 30, 2021 | 33,000.00 |
| Jun 30, 2021 | 79,000.00 |
| Jun 30, 2021 | 79,000.00 |